Mizuho keeps Outperform on Equifax, cuts price target to $185

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Mizuho analyst Sean Kennedy maintained an Outperform rating on Equifax
  • The price target was lowered from $210 to $185
  • The revision reflects a $25 reduction in valuation expectations
powered bylight_fuzz_icon
53959637

*this image is generated using AI for illustrative purposes only.

Equifax Inc saw its price target lowered to $185 by Mizuho analyst Sean Kennedy, who maintained an Outperform rating on the stock.

The adjustment represents a reduction of $25 from the previous target of $210. Despite the lower valuation ceiling, the analyst retained a positive stance on the company's outlook.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific macroeconomic factors or regulatory changes are driving Mizuho's decision to lower Equifax's price target despite maintaining an Outperform rating?

How might this valuation adjustment influence institutional investor sentiment and potential capital flows into the broader credit reporting sector?

Are there emerging competitive pressures from fintech alternatives or open banking initiatives that could impact Equifax's long-term revenue growth assumptions?

Oppenheimer downgrades Equifax to Perform from Outperform

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Oppenheimer analyst Rayna Kumar downgraded Equifax from Outperform to Perform
  • The rating change reflects a neutral stance on the stock's near-term performance
  • No additional financial data or target price revisions were provided in the source
powered bylight_fuzz_icon
53713756

*this image is generated using AI for illustrative purposes only.

Equifax Inc saw its investment rating lowered by Oppenheimer analyst Rayna Kumar, who moved the stock from Outperform to Perform.

The downgrade marks a shift in the firm's stance on the credit reporting agency. No specific financial metrics or target price adjustments were disclosed in the brief note regarding the rationale behind the rating change.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific regulatory or competitive pressures might be driving the shift in sentiment toward Equifax's core credit reporting business?

How could this downgrade influence institutional investor flows and overall market liquidity for Equifax in the short term?

Are there emerging data privacy regulations that could disproportionately impact Equifax's future revenue streams compared to peers?

More News on Equifax